RenovoRx maintains $3.75M-$4.25M 2026 revenue guidance as it targets 36 active cancer centers
What it means
- What to watch: There is a hard number in this story ($3) — the interesting part is how it compares with the last few like it.
- How the stock is trading: $RNXT -15.20% in the latest session.
- Timing: It dropped mid-session, while New York was open, so the move beside it may already include the market's first reaction.
Where the stock stands
$RNXT last traded at $1.01, -15.20% on the session. That puts it 61% shy of its 52-week high of $2.59 and 44% clear of its low of $0.70 — in the lower part of the range. Over the year it has ranged 269% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $RNXT page.
How much coverage it is getting
In the last 30 days Wook has filed 2 stories about $RNXT — 2 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal — something has the newsroom's attention. Across those stories 0 read bullish, 2 neutral and 0 bearish. This one reads neutral, so it sits in step with most of the run. 2 of the 2 (100%) came from Seeking Alpha itself, so the count says as much about how often Seeking Alpha hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$RNXT earnings in 6 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
The $RNXT page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $RNXT sits from its high, or how this week's coverage stacks up.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $RNXT. It carried $3.75 million and $4.25 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 6, 2026. $RNXT has moved -3.90% ($1.05 to $1.01). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.